In simple terms, a substance generally must meet one of these requirements: It has an official USP or National Formulary monograph It is already part of an FDA-approved drug product It appears on the FDAs official 503A Bulks List The important point is this: BPC-157, TB-500, and injectable GHK-Cu are not FDA-approved drugs, and they are not currently on the formal 503A Bulks List
Lancet Psychiatry 9 (11), 907921
Cobalamin (vitamin B 12 ) Deficiency Investigation & Management Early treatment of cobalamin deficiency is particularly important because neurologic symptoms may be irreversible
Using the ~15.7% figure derived earlier, and remembering that the parenteral nutrition reference range for adults is 0.30.5 mg (300500 g) of copper per day: [10] The widely repeated community figure of 1.7 mg/day delivers, by this estimate, roughly 267 g of copper directly into tissue the same order of magnitude as what a clinical team would deliver intravenously over a full day to a patient receiving all their nutrition parenterally, and which they would reduce, with monitoring of serum concentrations , in the presence of cholestasis because of accumulation risk